Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 200INDUSTRY 114NIH 56NETWORK 34OTHER_GOV 3FED 2

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 2Retinoblastoma 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Topotecan × Clear all
NCT02980809 2016-12-02

Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer

First Hospitals affiliated to the China PLA General Hospital

Phase 2 Unknown
60 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT02738346 2016-04-25

CBPC

University Hospital, Angers

Phase 3 Unknown
164 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00460876 2008-05-02

Phase I Trial of Periocular Topotecan in Retinoblastoma

Hospital JP Garrahan

Phase 1 Completed
5 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡